SlideShare a Scribd company logo
1 of 16
Download to read offline
2Q06 Results
 August, 2006
Company Overview




                   2
Company´s Overview

Grendene is one of the world´s largest producer of synthetic footwear, with
approximately 18 thousand employees, gross revenues of R$535 mn and 55.7
million pairs sold in 1H06.

                           Operates in 4 segments: men, women, kids and mass market.
  Market and brands        Strong brands.
                           Leadership in Kids.


                                        Synthetic and injected footwear on PVC and EVA
              Products                  Strong marketing culture and product differentiation



                           22,3 million pairs sold (2Q06)
     Market share          19% of Brazil´s production
                           15% of the Brazilian footwear exports


                                        Installed capacity of 176 million pairs/year
             Production                 In-house technology for plastic injection and production of moulds.
              capacity                  Strategic location of plants in State of Ceará creates important tax
                                        and labor cost advantages


                            Domestic market via sales representatives
                            External markets via direct exports and also through international subsidiaries
    Sales channels          and special sales division (Melissa line with selective distribution)
                            Around 17,300 sales point in Brazil and 19.500 averseas.
                                                                                                               3
Competitive differentials and strategy
                                       Strong and recognized brands, benchmark in synthetic footwear industry
                                       Capacity of creating and launching fashion trends at global level in the
      Strong brands                    segments it operates.
                                       Strategy of recognizing and identification in the products

                                               More selective focus in some products
                                               Greater volume leverage potential
                                               Higher added value products
                    Marketing and
                                               More concentrated media, fewer campaigns but with greater impact,
                 innovation capacity           to prolong the cycle of the product
                                               Analyzing niche markets to launch new brands, licenses and
                                               products

                                       Verticalized production and development of proprietary injection technology
    Distinct production                allow efficient, versatile and fast production on large scale, generating superior
    process with scale                 quality products at competitive prices, even when considering less value-added
                                       products.
                                       Ability to rapidly increase its installed capacity at low-cost

                                                  Highest corporate governance standards: listed at Novo Mercado
                   High corporate                 Dividend policy: up to 100% of the distributable net income
                  governance level                100% tag along rights and only voting shares
                                                  Independent members on the Board of Directors


                                       Gross revenues of R$249.7 mn in 2Q06 (R$261.2 mn in 2Q05)
                                       Adjusted EBITDA of R$38 mn in 2Q06 (R$17.1 mn in 2Q05)
  Solid financial structure            Adjusted net income of R$41.8 mn in 2Q06 (R$9 mn in 2Q05)
      and profitability                Net cash of R$473.8 mn in June 30, 2006
                                       R$ 189 mn cash provided by operating activities in June 30, 2006.


                                                                                                                            4
2Q06 & revised outlook

 Adjusted quartely net income, and 12-month net income: year-on-year changes

 450%
                                                                                              363%
 350%

 250%

 150%
                                            47%
  50%                                                        20%              11%
           -41%             -64%

 -50%      1Q05            2Q05             3Q05            4Q05             1Q06             2Q06
           -35%            -36%             -24%             -3%              14%              45%
 -150%
           12-month result: change year-on-year    Adjusted net income for the year, year-on-year change


                                                            CAGR: 29%p.a in adjusted net income
                                                               acumulated in 12M up to 2Q06
Guidance for 2006 are:
    2006 gross revenue in line with 2005 - with the possibility of a slight increase; and
    2006 sales volume in line with 2005 - with the possibility of a slight decrease.

                                                                                                           5
2Q06: proportionately lower fall in sales, and higher recovery in margins

            Gross revenue, adjusted Ebitda and adjusted net income - year-on-year changes, %
  400%

  300%

  200%

  100%

    0%
          1Q04/1Q03   2Q04/2Q03   3Q04/3Q03   4Q04/4Q03   1Q05/1Q04   2Q05/2Q04   3Q05/3Q04   4Q05/4Q04   1Q06/1Q05   2Q06/2Q05
  -100%
                                  Gross sales revenue        Adjusted Ebitda        Adjusted Net Income

 ▲ Trend to profitability being maintained: margins improvement due to continuous
    control of industrial costs and expenses but not a turnaround in sales yet;
 ▼ 2Q06 gross revenues low 4.4% YoY and sales volume 10.8% with average prices
    higher 7.2% due to higher added value product mix;
 ▲ Adjusted Ebitda up 123%, R$ 38 mn and margin of 19.3%, due to gross profit
    improvement and SG&A expenses reduction;
 ▲ Net income: R$ 42 mn, margin 21.2% of net sales (vs. R$9 mn and 4.4%);
 ▲ Non-recurring income of R$10mn (net of taxes and legal fees) in PIS/COFINS tax
    credits.
                                                                                                                                  6
2Q06 earnings – adjusted net income 363% up YoY ...

                          Main Financial and Economic Indicators
(R$ mn)                        2Q05             2Q06          Var.%    1H05           1H06            Var.%
Gross Revenues                 261.2            249.7          (4%)      575            535           (7%)
   Domestic                    226.0            217.3          (4%)      484            446           (8%)
   Exports                      35.2             32.4          (8%)       92             89           (3%)
Net Sales                      203.2            197.1          (3%)      452            425           (6%)
Gross Profit                    62.3    30.7%    72.9   37.0%  17%       155    34.3%   159   37.3%    2%
Adjusted EBITDA                 17.1    8.4%     38.0   19.3% 123%        67    14.8%    89   21.0%   33%
Net Financial Result            (2.7)            14.8           n.s.      (3)            22            n.s.
Adjusted Net Income              9.0    4.4%     41.8   21.2% 363%        46    10.2%    83   19.6%   80%
EPS (R$ per share)              0.09             0.42         364%         0              1           80%
Sales Volume (million pairs)    25.1             22.3         (11%)       56             56           (1%)
Average Price (R$)             10.42            11.17           7%     10.20           9.62           (6%)

▲ Gross profit: gross margin recovered from 31% to 37% of net sales due to 12%
    decrease in COGS (higher added value products – higher average price – costing
    less – stable COGs per pair)
▲ Financial management helped the net income: changing from net expenses of
    R$2.6 mn to net income of R$14.8mn due to FX exposure elimination;
▲ Interim dividends:    payment on 30/Aug/06, R$39mn (R$0.39 per common
    share), approximately 100% of distributable first half 2006 profit. To shareholders
    of record on 14/Aug/06. Ex-dividend on 15/Aug/06.
                                                                                                              7
Raw material costs: low correlation of our input cost per pair with
                                              petrochemicals price
      4,000                                                                                                                4.00




      3,000                                                                                                                3.00




      2,000                                                                                                                2.00




      1,000                                                                                                                1.00




        -                                                                                                                  -
            Jan-04   Apr-04    Jul-04      Oct-04       Feb-05    May-05       Aug-05    Dec-05     Mar-06        Jun-06

                      Plastifying oils (R$'000)       PVC resin (R$'000)       Our COGS in raw materials - (R$)
                                                  Fonte: ICIS-LOR / Grendene


Including all raw material, we produced and sold products with average price
increase (higher added value) costing less (lower raw material consumption);
Lower cost production (lower quantity and utilization of PVC) and higher price
of final product = margin gain
Influence factors: PVC resin price and plastifying oils; FX rate; design (variety of
models and plastic content)... all contributing to a stable cost per pair in 2Q06.
                                                                                                                                  8
Average price Vs. volume: adding value due to product mix, smaller
number of launches and focus on greater volume potential products
60%                                                                              R$ 12.00




40%                                                                              R$ 8.00
                                                                                              Higher average price ... due to
                                                                                               greater added value products
                                                                                                       launchings...
20%                                                                              R$ 4.00




0%                                                                               R$ -
      1Q04   2Q04   3Q04   4Q04    1Q05    2Q05   3Q05    4Q05    1Q06   2Q06
                           Gross margin, %     Average price (R$)

                                                           60%                                                                                     60




   ... with a greater potential in                         40%                                                                                     40

  terms of leverage in volume,
      without affects the gross
               margin.                                     20%                                                                                     20




                                                            0%                                                                                     -
                                                                  1Q04    2Q04     3Q04   4Q04     1Q05   2Q05     3Q05    4Q05      1Q06   2Q06
                                                                                      Gross margin, %     Sales volume (million pairs)
                                                                                                                                                        9
Selling expenses lower, from 27.3% to 25.3% of net sales, due to
advertising expenses reduction in 2Q06 ...
                Advertising expenses (R$ mn) - net sales, year-on-year change, %; and
                             domestic net sales, year-on-year change, %

                             10.7%                  10.8%
        9.5%                             9.6%
                    7.8%                                            8.2%                                  8.1%
                                                                                7.6%
                                                                                              6.4%                         Smaller number of
4.3%                            43                                                                                          launches and
                     26
                                                                                                                             campaigns...
                                           24          22            25            24
         20
                                                                                               15          16
 12

1Q04     2Q04        3Q04      4Q04       1Q05        2Q05           3Q05          4Q05       1Q06        2Q06

                               Advertising expenses (R$ mn)         Net sales, %



                                                               Advertising expenses as % of net sales: year-on-year change, basis points

                                                                                                    530
         ...and greater
        selectiveness in                                      350
       products for which                                                               290
                                                                          220
        we use TV ads.                                                                                          130
                                                                                                                      40

                                             1Q04/1Q03 2Q04/2Q03 3Q04/3Q03 4Q04/4Q03 1Q05/1Q04 2Q05/2Q04 3Q05/3Q04 4Q05/4Q04 1Q06/1Q05 2Q06/2Q05



                                              (190)
                                                                                                                                             (270)
                                                                                                                            (310)    (320)           10
Adjusted EBITDA: margin increased from 8.4% to 19.3% ...

      Adjusted Ebitda (R$ mn) and adjusted Ebitda margin, %

                                                  19.3%



                                                                                                    ... due to gross
       8.4%                                        38
                                                                                                          profit
                                                                                                     improvement...
         17


         2Q05                                      2Q06

           Adjusted Ebitda      Adjusted Ebitda margin, %
                                                        Change in Ebitda margin, y/y, as a % of net sales, in basis points


                                                                                                                               1,090
   ... and due to
        SG&A
     expenses                                                                                   490
                                                                            350
                                                                                                                     240
      decrease.
                                1Q05/1Q04            2Q05/2Q04           3Q05/3Q04            4Q05/4Q04           1Q06/1Q05   2Q06/2Q05




                                                        (690)
                                 (1,000)
                                                                                                                                          11
Seasonality... each quarter over total year



                                                                       Seasonality

60%
                                                        39%
50%
                                                                                    38%
                           30%
                    32%
40%                                                                                        22%                   33%                  28%
                                                                             24%                                                             29%
                                                  26%                                                     27%           23%
30%                               19%                          19%
      21%                                                             19%                                                                          21%
                                                                                                                               19%                       19%
             17%                                                                                  18%
20%                                      15%


10%

0%
      1Q01   2Q01   3Q01   4Q01   1Q02   2Q02    3Q02   4Q02   1Q03   2Q03   3Q03   4Q03   1Q04   2Q04    3Q04   4Q04   1Q05   2Q05   3Q05   4Q05 1Q06* 2Q06*
                                                                              Quarter

                                                Gross sales revenues (*)      Adjusted EBITDA           Adjusted Net Income



                                                  (*) Calculated based on the gross revenue guidance equal to 2005.




                                                                                                                                                           12
Debt


       Net cash R$ 473.8 million on Jun. 30, 2006

                                          26.3          27.1
                               27.2       152.8        153.1
  23.2         31.3
                              150.9
 131.1        141.0

                                                       654.0         Cost of debt at Jun. 30, 2006
                                          638.2
 449.0        476.5           510.8
                                                                     32%                            30%

 30/Jun/05    30/Sep/05       31/Dec/05   31/Mar/06    30/Jun/06


  Cash and cash equivalents     Long Term debt   Short term debt


                                                                                      38%

                                                                   IGP-M   Fixed rate (7.5% to 10.5%p.a.)   TJLP



                                                                                                               13
Outlook ...
                                     Recovery specially in the domestic market in 1H06
                                     2006-2207 spring-summer collection was very well accepted by the principal
    Recovery of growth               clients, store owners and retailers
         in sales                    Higher focus in the R&D and marketing strategies
                                     Spring-summer launches confirmation by consumers

                                                 Total wages higher than GDP
                                                 Lower inflation rate
                    Macroeconomic                Interest rate decreasing
                          scenario               Higher available credit
                                                 Longer payment terms in economics

                                     Hiring of the Management Development Institute in July 2006 to develop the
  Specialized consultants            project “Improving the Sales Management”
       in sales area                 Focused in sales increase
                                     INDG diagnosis will contribute for future strategic movements

                                                Gross revenue = 2005 or slightly > easy to calculate 2S06
                                                Sales volume = 2005 or slightly < easy to calculate 2S06
                    Guidance                    Average price up due to higher value added products
                                                Important historical data since the IPO will help the market projections
                                                Significant changes will be reported

                                     High net cash allows future strategic movements
                                     Three Interim dividends in 2006
  Sound financial situation          High general profitability
                                     Strong cash flow
                                     High leverage potential in the case of growth sales recovery


                                                                                                                      14
Grendene´s IR Team
•   Grendene IR team

    – Alexandre Grendene Bartelle
      CFO & IRD
      dri@grendene.com.br

    – Doris Wilhelm
      IRO
      doris@grendene.com.br
      (5554) 2109.9036 & (5554) 9166.0407

    – Alexandre Vizzotto
      Analyst
      avizzotto@grendene.com.br
      (5554) 2109.9011

    – Lenir Baretta
      Analyst
      lbaretta@grendene.com.br
      (5554) 2109.9026



                                            15
Warning



This presentation contains statements that might represent projections of
future events and results. These statements are based upon certain
assumptions and analyses performed by the company according to its
experience, economic environment, market conditions, and expected future
developments that might be out of the company’s control. Important facts
that may lead to significant differences between expected and actual
results, including the company’s business strategy, local and international
economic condition, technology, financial strategy, developments in the
shoes industry, equity market conditions, uncertainties concerning future
results, plans, expectations and intentions, and other facts. As a
consequence of these facts, the actual results may significantly differ from
the ones indicated and/or implied in the statements of projections
concerning future events and results.




                                                                               16

More Related Content

What's hot

Cdon group Q1 2013 and rights issue presentation
Cdon group Q1 2013 and rights issue presentationCdon group Q1 2013 and rights issue presentation
Cdon group Q1 2013 and rights issue presentationQliro Group AB
 
Apresentação 1 q12
Apresentação 1 q12Apresentação 1 q12
Apresentação 1 q12Cia Hering RI
 
monsanto 01_16_09
monsanto 01_16_09monsanto 01_16_09
monsanto 01_16_09finance28
 
BASF Roundtable Agricultural Solutions 2012
BASF Roundtable Agricultural Solutions 2012BASF Roundtable Agricultural Solutions 2012
BASF Roundtable Agricultural Solutions 2012BASF
 
2Q 2008 EARNINGSTRAN SCRIPT
2Q 2008 EARNINGSTRAN SCRIPT2Q 2008 EARNINGSTRAN SCRIPT
2Q 2008 EARNINGSTRAN SCRIPTfinance22
 
dover Q206_Slides
dover Q206_Slidesdover Q206_Slides
dover Q206_Slidesfinance30
 
Slide presentation 1 q10
Slide presentation 1 q10Slide presentation 1 q10
Slide presentation 1 q10Cia Hering RI
 
Celsius investor presentation
Celsius investor presentationCelsius investor presentation
Celsius investor presentationNeil Kimberley
 
Wessanen Q3 2011 analyst&investors presentation
Wessanen Q3 2011 analyst&investors presentationWessanen Q3 2011 analyst&investors presentation
Wessanen Q3 2011 analyst&investors presentationKlaus Arntz
 
FirstQuarter2006FinancialReviewandAnalysis
FirstQuarter2006FinancialReviewandAnalysisFirstQuarter2006FinancialReviewandAnalysis
FirstQuarter2006FinancialReviewandAnalysisfinance45
 
Presentation Results Q3 10/11
Presentation Results Q3 10/11Presentation Results Q3 10/11
Presentation Results Q3 10/11Barry Callebaut
 
Divulgação de resultados 2Q14
Divulgação de resultados 2Q14Divulgação de resultados 2Q14
Divulgação de resultados 2Q14Profarma
 
Brmalls 3 q11_eng
Brmalls 3 q11_engBrmalls 3 q11_eng
Brmalls 3 q11_engBRMALLS
 
Analyst meet 21stfeb12
Analyst meet 21stfeb12Analyst meet 21stfeb12
Analyst meet 21stfeb12washimsarkar
 

What's hot (17)

Cdon group Q1 2013 and rights issue presentation
Cdon group Q1 2013 and rights issue presentationCdon group Q1 2013 and rights issue presentation
Cdon group Q1 2013 and rights issue presentation
 
Analyst presentation q4 2019
Analyst presentation   q4 2019Analyst presentation   q4 2019
Analyst presentation q4 2019
 
2q11
2q112q11
2q11
 
Apresentação 1 q12
Apresentação 1 q12Apresentação 1 q12
Apresentação 1 q12
 
monsanto 01_16_09
monsanto 01_16_09monsanto 01_16_09
monsanto 01_16_09
 
BASF Roundtable Agricultural Solutions 2012
BASF Roundtable Agricultural Solutions 2012BASF Roundtable Agricultural Solutions 2012
BASF Roundtable Agricultural Solutions 2012
 
2Q 2008 EARNINGSTRAN SCRIPT
2Q 2008 EARNINGSTRAN SCRIPT2Q 2008 EARNINGSTRAN SCRIPT
2Q 2008 EARNINGSTRAN SCRIPT
 
3 q15
3 q153 q15
3 q15
 
dover Q206_Slides
dover Q206_Slidesdover Q206_Slides
dover Q206_Slides
 
Slide presentation 1 q10
Slide presentation 1 q10Slide presentation 1 q10
Slide presentation 1 q10
 
Celsius investor presentation
Celsius investor presentationCelsius investor presentation
Celsius investor presentation
 
Wessanen Q3 2011 analyst&investors presentation
Wessanen Q3 2011 analyst&investors presentationWessanen Q3 2011 analyst&investors presentation
Wessanen Q3 2011 analyst&investors presentation
 
FirstQuarter2006FinancialReviewandAnalysis
FirstQuarter2006FinancialReviewandAnalysisFirstQuarter2006FinancialReviewandAnalysis
FirstQuarter2006FinancialReviewandAnalysis
 
Presentation Results Q3 10/11
Presentation Results Q3 10/11Presentation Results Q3 10/11
Presentation Results Q3 10/11
 
Divulgação de resultados 2Q14
Divulgação de resultados 2Q14Divulgação de resultados 2Q14
Divulgação de resultados 2Q14
 
Brmalls 3 q11_eng
Brmalls 3 q11_engBrmalls 3 q11_eng
Brmalls 3 q11_eng
 
Analyst meet 21stfeb12
Analyst meet 21stfeb12Analyst meet 21stfeb12
Analyst meet 21stfeb12
 

Viewers also liked

Grendene - 1st Qquarter 2006 Earnings
Grendene - 1st Qquarter 2006 EarningsGrendene - 1st Qquarter 2006 Earnings
Grendene - 1st Qquarter 2006 EarningsGrendene
 
Grendene - 2nd Annual Brazil Conference Itaú Securies
Grendene - 2nd Annual Brazil Conference Itaú SecuriesGrendene - 2nd Annual Brazil Conference Itaú Securies
Grendene - 2nd Annual Brazil Conference Itaú SecuriesGrendene
 
ADHD Power Talk
ADHD Power TalkADHD Power Talk
ADHD Power Talkdianeo
 
Adhd Talk V3.0
Adhd Talk V3.0Adhd Talk V3.0
Adhd Talk V3.0dianeo
 
Pci Forensic What You Dont Know
Pci Forensic What You Dont KnowPci Forensic What You Dont Know
Pci Forensic What You Dont KnowDavid Barnett
 

Viewers also liked (6)

Grendene - 1st Qquarter 2006 Earnings
Grendene - 1st Qquarter 2006 EarningsGrendene - 1st Qquarter 2006 Earnings
Grendene - 1st Qquarter 2006 Earnings
 
Bathroom Fix
Bathroom FixBathroom Fix
Bathroom Fix
 
Grendene - 2nd Annual Brazil Conference Itaú Securies
Grendene - 2nd Annual Brazil Conference Itaú SecuriesGrendene - 2nd Annual Brazil Conference Itaú Securies
Grendene - 2nd Annual Brazil Conference Itaú Securies
 
ADHD Power Talk
ADHD Power TalkADHD Power Talk
ADHD Power Talk
 
Adhd Talk V3.0
Adhd Talk V3.0Adhd Talk V3.0
Adhd Talk V3.0
 
Pci Forensic What You Dont Know
Pci Forensic What You Dont KnowPci Forensic What You Dont Know
Pci Forensic What You Dont Know
 

Similar to Grendene - 2nd Qquarter 2006 Earnings

Benchmarking in a SaaS World
Benchmarking in a SaaS WorldBenchmarking in a SaaS World
Benchmarking in a SaaS WorldOPEXEngine
 
RD_220801_EarningsPresentation_2Q22.pdf
RD_220801_EarningsPresentation_2Q22.pdfRD_220801_EarningsPresentation_2Q22.pdf
RD_220801_EarningsPresentation_2Q22.pdfEnriqueG19
 
Q2 2016 Earnings Presentation - Bruker Corporation
Q2 2016 Earnings Presentation - Bruker CorporationQ2 2016 Earnings Presentation - Bruker Corporation
Q2 2016 Earnings Presentation - Bruker CorporationInvestorBruker
 
Bruker Q3'18 Earnings Slides
Bruker Q3'18 Earnings SlidesBruker Q3'18 Earnings Slides
Bruker Q3'18 Earnings SlidesInvestorBruker
 
Q2'18 earnings slides final 2 aug18
Q2'18 earnings slides final 2 aug18Q2'18 earnings slides final 2 aug18
Q2'18 earnings slides final 2 aug18InvestorBruker
 
Apres gpa earnings 2q21
Apres gpa earnings 2q21Apres gpa earnings 2q21
Apres gpa earnings 2q21OrlandoNeto43
 
Slide presentation 2 q10
Slide presentation 2 q10Slide presentation 2 q10
Slide presentation 2 q10Cia Hering RI
 
2Q12 Conference Call Presentation
2Q12 Conference Call Presentation2Q12 Conference Call Presentation
2Q12 Conference Call PresentationCia Hering RI
 
Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18InvestorBruker
 
30 06-2011 - 2 q11 earnings release
30 06-2011 - 2 q11 earnings release30 06-2011 - 2 q11 earnings release
30 06-2011 - 2 q11 earnings releasesonaeri
 
Hershey Presentation at 2024 CAGY Conference
Hershey Presentation at 2024 CAGY ConferenceHershey Presentation at 2024 CAGY Conference
Hershey Presentation at 2024 CAGY ConferenceNeil Kimberley
 
Barry Callebaut Group – Full-Year Results, Fiscal Year 2020/21 - Media & Anal...
Barry Callebaut Group – Full-Year Results, Fiscal Year 2020/21 - Media & Anal...Barry Callebaut Group – Full-Year Results, Fiscal Year 2020/21 - Media & Anal...
Barry Callebaut Group – Full-Year Results, Fiscal Year 2020/21 - Media & Anal...Barry Callebaut
 
Stock Market Report For Investors -Sai Proficient
Stock Market Report For Investors -Sai ProficientStock Market Report For Investors -Sai Proficient
Stock Market Report For Investors -Sai Proficientsai proficient research
 
Q2 earnings call slide deck 20171101 10am
Q2 earnings call slide deck 20171101 10amQ2 earnings call slide deck 20171101 10am
Q2 earnings call slide deck 20171101 10amacxiom2016ir
 
RIL-4Q-FY23-Analyst-Presentation.pdf
RIL-4Q-FY23-Analyst-Presentation.pdfRIL-4Q-FY23-Analyst-Presentation.pdf
RIL-4Q-FY23-Analyst-Presentation.pdfRACHNASAHA2
 

Similar to Grendene - 2nd Qquarter 2006 Earnings (20)

Presentation 4 q09
Presentation 4 q09Presentation 4 q09
Presentation 4 q09
 
3q11
3q113q11
3q11
 
Benchmarking in a SaaS World
Benchmarking in a SaaS WorldBenchmarking in a SaaS World
Benchmarking in a SaaS World
 
RD_220801_EarningsPresentation_2Q22.pdf
RD_220801_EarningsPresentation_2Q22.pdfRD_220801_EarningsPresentation_2Q22.pdf
RD_220801_EarningsPresentation_2Q22.pdf
 
Q2 2016 Earnings Presentation - Bruker Corporation
Q2 2016 Earnings Presentation - Bruker CorporationQ2 2016 Earnings Presentation - Bruker Corporation
Q2 2016 Earnings Presentation - Bruker Corporation
 
Presentation 2013
Presentation 2013Presentation 2013
Presentation 2013
 
Bruker Q3'18 Earnings Slides
Bruker Q3'18 Earnings SlidesBruker Q3'18 Earnings Slides
Bruker Q3'18 Earnings Slides
 
Q2'18 earnings slides final 2 aug18
Q2'18 earnings slides final 2 aug18Q2'18 earnings slides final 2 aug18
Q2'18 earnings slides final 2 aug18
 
Apres gpa earnings 2q21
Apres gpa earnings 2q21Apres gpa earnings 2q21
Apres gpa earnings 2q21
 
Slide presentation 2 q10
Slide presentation 2 q10Slide presentation 2 q10
Slide presentation 2 q10
 
2Q12 Conference Call Presentation
2Q12 Conference Call Presentation2Q12 Conference Call Presentation
2Q12 Conference Call Presentation
 
Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18
 
30 06-2011 - 2 q11 earnings release
30 06-2011 - 2 q11 earnings release30 06-2011 - 2 q11 earnings release
30 06-2011 - 2 q11 earnings release
 
Hershey Presentation at 2024 CAGY Conference
Hershey Presentation at 2024 CAGY ConferenceHershey Presentation at 2024 CAGY Conference
Hershey Presentation at 2024 CAGY Conference
 
Barry Callebaut Group – Full-Year Results, Fiscal Year 2020/21 - Media & Anal...
Barry Callebaut Group – Full-Year Results, Fiscal Year 2020/21 - Media & Anal...Barry Callebaut Group – Full-Year Results, Fiscal Year 2020/21 - Media & Anal...
Barry Callebaut Group – Full-Year Results, Fiscal Year 2020/21 - Media & Anal...
 
Q317 earnings slides
Q317 earnings slidesQ317 earnings slides
Q317 earnings slides
 
Stock Market Report For Investors -Sai Proficient
Stock Market Report For Investors -Sai ProficientStock Market Report For Investors -Sai Proficient
Stock Market Report For Investors -Sai Proficient
 
Piaggio Group - First Nine Months 2011 Financial Results
Piaggio Group - First Nine Months 2011 Financial ResultsPiaggio Group - First Nine Months 2011 Financial Results
Piaggio Group - First Nine Months 2011 Financial Results
 
Q2 earnings call slide deck 20171101 10am
Q2 earnings call slide deck 20171101 10amQ2 earnings call slide deck 20171101 10am
Q2 earnings call slide deck 20171101 10am
 
RIL-4Q-FY23-Analyst-Presentation.pdf
RIL-4Q-FY23-Analyst-Presentation.pdfRIL-4Q-FY23-Analyst-Presentation.pdf
RIL-4Q-FY23-Analyst-Presentation.pdf
 

More from Grendene

Grendene - Brazil Day 2008
Grendene - Brazil Day 2008Grendene - Brazil Day 2008
Grendene - Brazil Day 2008Grendene
 
Grendene - APIMEC Meeting - August 2009
Grendene - APIMEC Meeting - August 2009Grendene - APIMEC Meeting - August 2009
Grendene - APIMEC Meeting - August 2009Grendene
 
Grendene - Brazil 2008 - 9th Annual CEO Conference - UBS Pactual
Grendene - Brazil 2008 - 9th Annual CEO Conference - UBS PactualGrendene - Brazil 2008 - 9th Annual CEO Conference - UBS Pactual
Grendene - Brazil 2008 - 9th Annual CEO Conference - UBS PactualGrendene
 
Grendene - 1st Annual Brazil Conference Itaú Securies
Grendene - 1st Annual Brazil Conference Itaú SecuriesGrendene - 1st Annual Brazil Conference Itaú Securies
Grendene - 1st Annual Brazil Conference Itaú SecuriesGrendene
 
Grendene - 15th Annual Latin America Conference - Citigroup
Grendene - 15th Annual Latin America Conference - CitigroupGrendene - 15th Annual Latin America Conference - Citigroup
Grendene - 15th Annual Latin America Conference - CitigroupGrendene
 
Grendene - 2nd Qquarter 2007 Earnings
Grendene - 2nd Qquarter 2007 EarningsGrendene - 2nd Qquarter 2007 Earnings
Grendene - 2nd Qquarter 2007 EarningsGrendene
 
Grendene - 3rd Qquarter 2007 Earnings
Grendene - 3rd Qquarter 2007 EarningsGrendene - 3rd Qquarter 2007 Earnings
Grendene - 3rd Qquarter 2007 EarningsGrendene
 

More from Grendene (7)

Grendene - Brazil Day 2008
Grendene - Brazil Day 2008Grendene - Brazil Day 2008
Grendene - Brazil Day 2008
 
Grendene - APIMEC Meeting - August 2009
Grendene - APIMEC Meeting - August 2009Grendene - APIMEC Meeting - August 2009
Grendene - APIMEC Meeting - August 2009
 
Grendene - Brazil 2008 - 9th Annual CEO Conference - UBS Pactual
Grendene - Brazil 2008 - 9th Annual CEO Conference - UBS PactualGrendene - Brazil 2008 - 9th Annual CEO Conference - UBS Pactual
Grendene - Brazil 2008 - 9th Annual CEO Conference - UBS Pactual
 
Grendene - 1st Annual Brazil Conference Itaú Securies
Grendene - 1st Annual Brazil Conference Itaú SecuriesGrendene - 1st Annual Brazil Conference Itaú Securies
Grendene - 1st Annual Brazil Conference Itaú Securies
 
Grendene - 15th Annual Latin America Conference - Citigroup
Grendene - 15th Annual Latin America Conference - CitigroupGrendene - 15th Annual Latin America Conference - Citigroup
Grendene - 15th Annual Latin America Conference - Citigroup
 
Grendene - 2nd Qquarter 2007 Earnings
Grendene - 2nd Qquarter 2007 EarningsGrendene - 2nd Qquarter 2007 Earnings
Grendene - 2nd Qquarter 2007 Earnings
 
Grendene - 3rd Qquarter 2007 Earnings
Grendene - 3rd Qquarter 2007 EarningsGrendene - 3rd Qquarter 2007 Earnings
Grendene - 3rd Qquarter 2007 Earnings
 

Recently uploaded

Deutsche EuroShop | Preliminary Results FY 2023
Deutsche EuroShop | Preliminary Results FY 2023Deutsche EuroShop | Preliminary Results FY 2023
Deutsche EuroShop | Preliminary Results FY 2023Deutsche EuroShop AG
 
Deutsche EuroShop | Company Presentation | 03/24
Deutsche EuroShop | Company Presentation | 03/24Deutsche EuroShop | Company Presentation | 03/24
Deutsche EuroShop | Company Presentation | 03/24Deutsche EuroShop AG
 
Terna Capital Markets Day 2024 Presentation
Terna Capital Markets Day 2024 PresentationTerna Capital Markets Day 2024 Presentation
Terna Capital Markets Day 2024 PresentationTerna SpA
 
Osisko Gold Royalties Ltd - Corporate Presentation, March 2024
Osisko Gold Royalties Ltd - Corporate Presentation, March 2024Osisko Gold Royalties Ltd - Corporate Presentation, March 2024
Osisko Gold Royalties Ltd - Corporate Presentation, March 2024Osisko Gold Royalties Ltd
 
Advancing Discovery New Craigmont Project’s High-grade Copper Potential
Advancing Discovery New Craigmont Project’s High-grade Copper PotentialAdvancing Discovery New Craigmont Project’s High-grade Copper Potential
Advancing Discovery New Craigmont Project’s High-grade Copper Potentialnicola_mining
 
Nicola Mining Inc. Corporate Presentation March 2024
Nicola Mining Inc. Corporate Presentation March 2024Nicola Mining Inc. Corporate Presentation March 2024
Nicola Mining Inc. Corporate Presentation March 2024nicola_mining
 
WWW.SOFTSOP.COM PITCH DECK PRESENTATION.PDF
WWW.SOFTSOP.COM PITCH DECK PRESENTATION.PDFWWW.SOFTSOP.COM PITCH DECK PRESENTATION.PDF
WWW.SOFTSOP.COM PITCH DECK PRESENTATION.PDFMichael Claudio
 

Recently uploaded (7)

Deutsche EuroShop | Preliminary Results FY 2023
Deutsche EuroShop | Preliminary Results FY 2023Deutsche EuroShop | Preliminary Results FY 2023
Deutsche EuroShop | Preliminary Results FY 2023
 
Deutsche EuroShop | Company Presentation | 03/24
Deutsche EuroShop | Company Presentation | 03/24Deutsche EuroShop | Company Presentation | 03/24
Deutsche EuroShop | Company Presentation | 03/24
 
Terna Capital Markets Day 2024 Presentation
Terna Capital Markets Day 2024 PresentationTerna Capital Markets Day 2024 Presentation
Terna Capital Markets Day 2024 Presentation
 
Osisko Gold Royalties Ltd - Corporate Presentation, March 2024
Osisko Gold Royalties Ltd - Corporate Presentation, March 2024Osisko Gold Royalties Ltd - Corporate Presentation, March 2024
Osisko Gold Royalties Ltd - Corporate Presentation, March 2024
 
Advancing Discovery New Craigmont Project’s High-grade Copper Potential
Advancing Discovery New Craigmont Project’s High-grade Copper PotentialAdvancing Discovery New Craigmont Project’s High-grade Copper Potential
Advancing Discovery New Craigmont Project’s High-grade Copper Potential
 
Nicola Mining Inc. Corporate Presentation March 2024
Nicola Mining Inc. Corporate Presentation March 2024Nicola Mining Inc. Corporate Presentation March 2024
Nicola Mining Inc. Corporate Presentation March 2024
 
WWW.SOFTSOP.COM PITCH DECK PRESENTATION.PDF
WWW.SOFTSOP.COM PITCH DECK PRESENTATION.PDFWWW.SOFTSOP.COM PITCH DECK PRESENTATION.PDF
WWW.SOFTSOP.COM PITCH DECK PRESENTATION.PDF
 

Grendene - 2nd Qquarter 2006 Earnings

  • 3. Company´s Overview Grendene is one of the world´s largest producer of synthetic footwear, with approximately 18 thousand employees, gross revenues of R$535 mn and 55.7 million pairs sold in 1H06. Operates in 4 segments: men, women, kids and mass market. Market and brands Strong brands. Leadership in Kids. Synthetic and injected footwear on PVC and EVA Products Strong marketing culture and product differentiation 22,3 million pairs sold (2Q06) Market share 19% of Brazil´s production 15% of the Brazilian footwear exports Installed capacity of 176 million pairs/year Production In-house technology for plastic injection and production of moulds. capacity Strategic location of plants in State of Ceará creates important tax and labor cost advantages Domestic market via sales representatives External markets via direct exports and also through international subsidiaries Sales channels and special sales division (Melissa line with selective distribution) Around 17,300 sales point in Brazil and 19.500 averseas. 3
  • 4. Competitive differentials and strategy Strong and recognized brands, benchmark in synthetic footwear industry Capacity of creating and launching fashion trends at global level in the Strong brands segments it operates. Strategy of recognizing and identification in the products More selective focus in some products Greater volume leverage potential Higher added value products Marketing and More concentrated media, fewer campaigns but with greater impact, innovation capacity to prolong the cycle of the product Analyzing niche markets to launch new brands, licenses and products Verticalized production and development of proprietary injection technology Distinct production allow efficient, versatile and fast production on large scale, generating superior process with scale quality products at competitive prices, even when considering less value-added products. Ability to rapidly increase its installed capacity at low-cost Highest corporate governance standards: listed at Novo Mercado High corporate Dividend policy: up to 100% of the distributable net income governance level 100% tag along rights and only voting shares Independent members on the Board of Directors Gross revenues of R$249.7 mn in 2Q06 (R$261.2 mn in 2Q05) Adjusted EBITDA of R$38 mn in 2Q06 (R$17.1 mn in 2Q05) Solid financial structure Adjusted net income of R$41.8 mn in 2Q06 (R$9 mn in 2Q05) and profitability Net cash of R$473.8 mn in June 30, 2006 R$ 189 mn cash provided by operating activities in June 30, 2006. 4
  • 5. 2Q06 & revised outlook Adjusted quartely net income, and 12-month net income: year-on-year changes 450% 363% 350% 250% 150% 47% 50% 20% 11% -41% -64% -50% 1Q05 2Q05 3Q05 4Q05 1Q06 2Q06 -35% -36% -24% -3% 14% 45% -150% 12-month result: change year-on-year Adjusted net income for the year, year-on-year change CAGR: 29%p.a in adjusted net income acumulated in 12M up to 2Q06 Guidance for 2006 are: 2006 gross revenue in line with 2005 - with the possibility of a slight increase; and 2006 sales volume in line with 2005 - with the possibility of a slight decrease. 5
  • 6. 2Q06: proportionately lower fall in sales, and higher recovery in margins Gross revenue, adjusted Ebitda and adjusted net income - year-on-year changes, % 400% 300% 200% 100% 0% 1Q04/1Q03 2Q04/2Q03 3Q04/3Q03 4Q04/4Q03 1Q05/1Q04 2Q05/2Q04 3Q05/3Q04 4Q05/4Q04 1Q06/1Q05 2Q06/2Q05 -100% Gross sales revenue Adjusted Ebitda Adjusted Net Income ▲ Trend to profitability being maintained: margins improvement due to continuous control of industrial costs and expenses but not a turnaround in sales yet; ▼ 2Q06 gross revenues low 4.4% YoY and sales volume 10.8% with average prices higher 7.2% due to higher added value product mix; ▲ Adjusted Ebitda up 123%, R$ 38 mn and margin of 19.3%, due to gross profit improvement and SG&A expenses reduction; ▲ Net income: R$ 42 mn, margin 21.2% of net sales (vs. R$9 mn and 4.4%); ▲ Non-recurring income of R$10mn (net of taxes and legal fees) in PIS/COFINS tax credits. 6
  • 7. 2Q06 earnings – adjusted net income 363% up YoY ... Main Financial and Economic Indicators (R$ mn) 2Q05 2Q06 Var.% 1H05 1H06 Var.% Gross Revenues 261.2 249.7 (4%) 575 535 (7%) Domestic 226.0 217.3 (4%) 484 446 (8%) Exports 35.2 32.4 (8%) 92 89 (3%) Net Sales 203.2 197.1 (3%) 452 425 (6%) Gross Profit 62.3 30.7% 72.9 37.0% 17% 155 34.3% 159 37.3% 2% Adjusted EBITDA 17.1 8.4% 38.0 19.3% 123% 67 14.8% 89 21.0% 33% Net Financial Result (2.7) 14.8 n.s. (3) 22 n.s. Adjusted Net Income 9.0 4.4% 41.8 21.2% 363% 46 10.2% 83 19.6% 80% EPS (R$ per share) 0.09 0.42 364% 0 1 80% Sales Volume (million pairs) 25.1 22.3 (11%) 56 56 (1%) Average Price (R$) 10.42 11.17 7% 10.20 9.62 (6%) ▲ Gross profit: gross margin recovered from 31% to 37% of net sales due to 12% decrease in COGS (higher added value products – higher average price – costing less – stable COGs per pair) ▲ Financial management helped the net income: changing from net expenses of R$2.6 mn to net income of R$14.8mn due to FX exposure elimination; ▲ Interim dividends: payment on 30/Aug/06, R$39mn (R$0.39 per common share), approximately 100% of distributable first half 2006 profit. To shareholders of record on 14/Aug/06. Ex-dividend on 15/Aug/06. 7
  • 8. Raw material costs: low correlation of our input cost per pair with petrochemicals price 4,000 4.00 3,000 3.00 2,000 2.00 1,000 1.00 - - Jan-04 Apr-04 Jul-04 Oct-04 Feb-05 May-05 Aug-05 Dec-05 Mar-06 Jun-06 Plastifying oils (R$'000) PVC resin (R$'000) Our COGS in raw materials - (R$) Fonte: ICIS-LOR / Grendene Including all raw material, we produced and sold products with average price increase (higher added value) costing less (lower raw material consumption); Lower cost production (lower quantity and utilization of PVC) and higher price of final product = margin gain Influence factors: PVC resin price and plastifying oils; FX rate; design (variety of models and plastic content)... all contributing to a stable cost per pair in 2Q06. 8
  • 9. Average price Vs. volume: adding value due to product mix, smaller number of launches and focus on greater volume potential products 60% R$ 12.00 40% R$ 8.00 Higher average price ... due to greater added value products launchings... 20% R$ 4.00 0% R$ - 1Q04 2Q04 3Q04 4Q04 1Q05 2Q05 3Q05 4Q05 1Q06 2Q06 Gross margin, % Average price (R$) 60% 60 ... with a greater potential in 40% 40 terms of leverage in volume, without affects the gross margin. 20% 20 0% - 1Q04 2Q04 3Q04 4Q04 1Q05 2Q05 3Q05 4Q05 1Q06 2Q06 Gross margin, % Sales volume (million pairs) 9
  • 10. Selling expenses lower, from 27.3% to 25.3% of net sales, due to advertising expenses reduction in 2Q06 ... Advertising expenses (R$ mn) - net sales, year-on-year change, %; and domestic net sales, year-on-year change, % 10.7% 10.8% 9.5% 9.6% 7.8% 8.2% 8.1% 7.6% 6.4% Smaller number of 4.3% 43 launches and 26 campaigns... 24 22 25 24 20 15 16 12 1Q04 2Q04 3Q04 4Q04 1Q05 2Q05 3Q05 4Q05 1Q06 2Q06 Advertising expenses (R$ mn) Net sales, % Advertising expenses as % of net sales: year-on-year change, basis points 530 ...and greater selectiveness in 350 products for which 290 220 we use TV ads. 130 40 1Q04/1Q03 2Q04/2Q03 3Q04/3Q03 4Q04/4Q03 1Q05/1Q04 2Q05/2Q04 3Q05/3Q04 4Q05/4Q04 1Q06/1Q05 2Q06/2Q05 (190) (270) (310) (320) 10
  • 11. Adjusted EBITDA: margin increased from 8.4% to 19.3% ... Adjusted Ebitda (R$ mn) and adjusted Ebitda margin, % 19.3% ... due to gross 8.4% 38 profit improvement... 17 2Q05 2Q06 Adjusted Ebitda Adjusted Ebitda margin, % Change in Ebitda margin, y/y, as a % of net sales, in basis points 1,090 ... and due to SG&A expenses 490 350 240 decrease. 1Q05/1Q04 2Q05/2Q04 3Q05/3Q04 4Q05/4Q04 1Q06/1Q05 2Q06/2Q05 (690) (1,000) 11
  • 12. Seasonality... each quarter over total year Seasonality 60% 39% 50% 38% 30% 32% 40% 22% 33% 28% 24% 29% 26% 27% 23% 30% 19% 19% 21% 19% 21% 19% 19% 17% 18% 20% 15% 10% 0% 1Q01 2Q01 3Q01 4Q01 1Q02 2Q02 3Q02 4Q02 1Q03 2Q03 3Q03 4Q03 1Q04 2Q04 3Q04 4Q04 1Q05 2Q05 3Q05 4Q05 1Q06* 2Q06* Quarter Gross sales revenues (*) Adjusted EBITDA Adjusted Net Income (*) Calculated based on the gross revenue guidance equal to 2005. 12
  • 13. Debt Net cash R$ 473.8 million on Jun. 30, 2006 26.3 27.1 27.2 152.8 153.1 23.2 31.3 150.9 131.1 141.0 654.0 Cost of debt at Jun. 30, 2006 638.2 449.0 476.5 510.8 32% 30% 30/Jun/05 30/Sep/05 31/Dec/05 31/Mar/06 30/Jun/06 Cash and cash equivalents Long Term debt Short term debt 38% IGP-M Fixed rate (7.5% to 10.5%p.a.) TJLP 13
  • 14. Outlook ... Recovery specially in the domestic market in 1H06 2006-2207 spring-summer collection was very well accepted by the principal Recovery of growth clients, store owners and retailers in sales Higher focus in the R&D and marketing strategies Spring-summer launches confirmation by consumers Total wages higher than GDP Lower inflation rate Macroeconomic Interest rate decreasing scenario Higher available credit Longer payment terms in economics Hiring of the Management Development Institute in July 2006 to develop the Specialized consultants project “Improving the Sales Management” in sales area Focused in sales increase INDG diagnosis will contribute for future strategic movements Gross revenue = 2005 or slightly > easy to calculate 2S06 Sales volume = 2005 or slightly < easy to calculate 2S06 Guidance Average price up due to higher value added products Important historical data since the IPO will help the market projections Significant changes will be reported High net cash allows future strategic movements Three Interim dividends in 2006 Sound financial situation High general profitability Strong cash flow High leverage potential in the case of growth sales recovery 14
  • 15. Grendene´s IR Team • Grendene IR team – Alexandre Grendene Bartelle CFO & IRD dri@grendene.com.br – Doris Wilhelm IRO doris@grendene.com.br (5554) 2109.9036 & (5554) 9166.0407 – Alexandre Vizzotto Analyst avizzotto@grendene.com.br (5554) 2109.9011 – Lenir Baretta Analyst lbaretta@grendene.com.br (5554) 2109.9026 15
  • 16. Warning This presentation contains statements that might represent projections of future events and results. These statements are based upon certain assumptions and analyses performed by the company according to its experience, economic environment, market conditions, and expected future developments that might be out of the company’s control. Important facts that may lead to significant differences between expected and actual results, including the company’s business strategy, local and international economic condition, technology, financial strategy, developments in the shoes industry, equity market conditions, uncertainties concerning future results, plans, expectations and intentions, and other facts. As a consequence of these facts, the actual results may significantly differ from the ones indicated and/or implied in the statements of projections concerning future events and results. 16